Ovarian cancer is the most common type of gynecologic malignancy. Despite advances in surgery and chemotherapy, the survival rate is still low since most ovarian cancers relapse and become drug-resistant. Chemokines are small chemoattractant peptides mainly involved in the immune responses. More recently, chemokines were also demonstrated to...
-
2010 (v1)PublicationUploaded on: April 14, 2023
-
1999 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2002 (v1)Publication
No description
Uploaded on: March 31, 2023 -
1993 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2000 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2001 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2014 (v1)Publication
Chemokines are crucial autocrine and paracrine players in tumor development. In particular, CXCL12, through its receptors CXCR4 and CXCR7, affects tumor progression by controlling cancer cell survival, proliferation and migration, and, indirectly, via angiogenesis or recruiting immune cells. Glioblastoma (GBM) is the most prevalent primary...
Uploaded on: April 14, 2023 -
2016 (v1)Publication
Drug repositioning is gaining increasing attention in drug discovery because it represents a smart way to exploit new molecular targets of a known drug or target promiscuity among diverse diseases, for medical uses different from the one originally considered. In this review, we focus on known non-oncological drugs with new therapeutic...
Uploaded on: April 14, 2023 -
2007 (v1)Publication
Chemokines are key factors involved in the regulation of immune response, through the activation and control of leukocyte traffic, lymphopoiesis and immune surveillance. However, a large number of chemokines and their receptors are expressed in central nervous system (CNS) cells, either constitutively or induced by inflammatory stimuli, playing...
Uploaded on: April 14, 2023 -
2003 (v1)Publication
The study of chemokine role in the CNS indubitably represents an important step to understanding many aspects of brain pathology, physiology and development. Here we discuss our recent research on the expression of chemokines and chemokine receptors in brain tissues and in cultured CNS cells, with particular regard to the CXCL12/SDF-1-CXCR4...
Uploaded on: March 25, 2023 -
1999 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2016 (v1)Publication
Introduction: Chemokines control homing and trafficking of leukocytes in bone marrow and lymphoid organs. In particular, CXCL12 and its receptors CXCR4/CXCR7 control the homeostasis of multiple organs and systems. Their overexpression is linked to tumor development, both through a direct modulation of neoplastic cell proliferation, survival,...
Uploaded on: April 14, 2023 -
1999 (v1)Publication
No description
Uploaded on: December 2, 2022 -
2001 (v1)Publication
No description
Uploaded on: March 27, 2023 -
2013 (v1)Publication
Glioblastoma multiforme (GBM) is among the most devastating human tumors being rapidly fatal despite aggressive surgery, radiation and chemotherapies. It is characterized by extensive dissemination of tumor cells within the brain that hinders complete surgical resection. GBM tumor initiating-cells (TICs) are a rare subpopulation of cells...
Uploaded on: April 14, 2023 -
2008 (v1)Publication
Somatostatin inhibits cell proliferation through the activation of five receptors (SSTR1-5) expressed in normal and cancer cells. We analyzed the role of individual SSTRs in the antiproliferative activity of somatostatin in C6 rat glioma cells. Somatostatin dose-dependently inhibited C6 proliferation, an effect mimicked, with different efficacy...
Uploaded on: March 27, 2023 -
2013 (v1)Publication
Cancer stem cells (CSCs) or tumor initiating cells (TICs) drive glioblastoma (GBM) development, invasiveness and drug resistance. Distinct molecular pathways might regulate CSC biology as compared to cells in the bulk tumor mass, representing potential therapeutic targets. Chemokine CXCL12 and its receptor CXCR4 control proliferation, invasion...
Uploaded on: April 14, 2023 -
2000 (v1)Publication
The mitogen activated protein (MAP) kinase cascade represents one of the major regulator of cell growth by hormones and growth factors. However, although the activation of this intracellular pathway has been often regarded as mediator of cell proliferation, in many cell types the increase in MAP kinase (also called extra-cellular signal...
Uploaded on: April 14, 2023 -
2003 (v1)Publication
Pyrrolidinedithiocarbamate (PDTC) is a compound displaying antioxidant, pro-oxidant and metal chelator properties in different cell types. It has been described that PDTC may exert either anti-apoptotic or apoptotic activity. Moreover it is known that this agent regulates the activity of redox-sensitive transcription factors, such as AP-1 and...
Uploaded on: April 14, 2023 -
1999 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2006 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2005 (v1)Publication
Ovarian cancer (OC) is the leading cause of death in gynecologic diseases in which there is evidence for a complex chemokine network. Chemokines are a family of proteins that play an important role in tumor progression influencing cell proliferation, angiogenic/angiostatic processes, cell migration and metastasis, and, finally, regulating the...
Uploaded on: May 11, 2023 -
2011 (v1)Publication
Malignant pleural mesothelioma (MPM) is an aggressive chemotherapy-resistant cancer. Up-regulation of epidermal growth factor receptor (EGFR) plays an important role in MPM development and EGFRtyrosine kinase inhibitors (TKIs) may represent novel therapeutic options. We tested the effects of the EGFR TKIs gefitinib and erlotinib and TKIs...
Uploaded on: April 14, 2023